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Abstract
Background: Regional incidence trends in regular heroin use are important for assessing the
effectiveness of drug policies and for forecasting potential future epidemics.
Methods: To estimate incidence trends we applied both the more traditional Reporting Delay
Adjustment (RDA) method as well as the new and less data demanding General Inclusion Function
(GIF) method. The latter describes the probability of an individual being in substitution treatment
depending on time since the onset of heroin use. Data on year of birth, age at first regular heroin
use and date of admission to and cessation of substitution treatment was available from 1997 to
2006 for 11 of the 26 regions (cantons) of Switzerland. For the remaining cantons, we used the
number of patients in 5-year age group categories published in annual statistics between 1999 and
2006.
Results: Application of the RDA and GIF methods on data from the whole of Switzerland
produced equivalent incidence trends. The GIF method revealed similar incidence trends in all of
the Swiss cantons. Imputing a constant age of onset of 21 years resulted in almost equal trends to
those obtained when real age of onset was used. The cantonal incidence estimates revealed that in
the mid 80s there were high incidence rates in various regions distributed throughout all of the
linguistic areas in Switzerland. During the following years these regional differences disappeared
and the incidence of regular heroin use stabilized at a low level throughout the country.
Conclusion: It has been demonstrated that even with incomplete data the GIF method allows to
calculate accurate regional incidence trends.
Background
A lack of information about trends in the incidence of
regular heroin use hinders effective drug policy and
public health action. Yet incidence trends are still
unknown almost everywhere in the world. Various
estimation methods have been developed to estimate
the incidence of heroin use [1-4], however they have
requirements, like long-term treatment data or reliable
drug mortality statistics, which are rarely available. We
have recently reported estimates of incidence and
prevalence trends in regular heroin use in Zurich,
Switzerland [5]. These estimates were produced using
the Reporting Delay Adjustment (RDA) method and
were based on data from a long-term case register that
covered all methadone treatments for more than a
decade. The RDA method led to prevalence estimates
that were in good accord with prevalence estimates
generated by other approaches. We have also developed
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heroin use, called the General Inclusion Function (GIF)
method, which only requires methadone treatment data
from a single day [6]. On the premise that heroin
dependence is usually a chronic condition, we have
hypothesized that if governmental regulations do not
restrict access the probability of an individual being in
substitution treatment depends largely upon time since
onset of regular heroin use. The GIF approach led to
reasonably good incidence estimates in the canton of
Zurich, despite the presence of open drug scenes and
irrespective of whether onset of regular heroin use
occurred during an early or a late phase of the 'heroin
epidemic'.
To explore if the GIF method yields plausible incidence
estimates in other regions, we decided to apply it to
other Swiss cantons. There are several advantages of
using other areas in Switzerland to test the GIF method.
First, even though incidence trends in regular heroin use
are unknown in almost all regions, drug mortality trends
and the stable number of patients in substitution
treatment suggest that prevalence trends are similar
throughout Switzerland. Second, each of the 26 cantons
in Switzerland is individually responsible for treatment
provision and data collection. Third, the size of the
population of regular heroin users differs vastly between
cantons. For example, in 2003, the annual number of
individuals in methadone treatment in various cantons
ranged from 3 to 3,592 [7]. Therefore, by using separate
datasets that should yield similar incidence trends in
each canton, we can determine the smallest area to
which the GIF method can be applied.
Unfortunately, not every Swiss canton has a methadone
treatment register that includes data on the year of first
regular heroin use. Since heroin use usually occurs early
in life [1], when data on the age of heroin onset are
missing, an estimate of the number of affected indivi-
duals in each birth cohort may be used as an
approximation for incidence estimates. A benefit of
using data collected on the year of birth of patients in
substitution treatment is that it probably contains fewer
errors than age at first regular heroin use. If we find
similar incidence estimates in several adjacent regions
and similarly affected birth cohorts, estimates on birth
cohorts in the remaining regions would be sufficient to
draw a rough picture on how a 'heroin wave' has spread
over the whole area.
Thus, the aims of this paper are to: (i) estimate the
i n c i d e n c eo fr e g u l a rh e r o i nu s ef o rt h ew h o l eo f
Switzerland using the Reporting Delay Adjustment
(RDA) method; (ii) ascertain a General Inclusion
Function (GIF) for the whole of Switzerland by using
the annual number of patients in substitution treatment;
(iii) apply the GIF function to treatment data from
different calendar years, using data on 'year of first
heroin use' as well as 'year of birth'; and (iv) examine if
assuming a constant age of onset leads to acceptable
incidence trend approximations in all Swiss cantons.
Methods
Study area
Open drug scenes started to develop in Switzerland in
the early 1980s, mainly in the city of Zurich, but also in
other German speaking parts of Switzerland. The French
and Italian speaking parts of Switzerland were not
affected. Thus, linguistic regions may differ concerning
the development of the heroin wave. In February 1995,
the last open drug scenes in Zurich, Solothurn, and
Olten were closed; those in Bern, Basel-Stadt, and St.
Gallen had been closed earlier [8].
Methadone treatment registers
The Swiss law on narcotics requires that treatment
providers obtain permission from cantonal health
authorities to prescribe opioids to people dependent
on heroin. The law also requires a register of substitution
treatments provided to opioid dependent persons. Each
of the 26 Swiss cantons is responsible for methadone
treatment provision and data collection. The Swiss
Federal Office of Public Health has collated and
published annual statistics from all cantons since 1999
[7]. Since 2002, it has provided a computer program to
all interested cantons by which more detailed treatment
data can be collected and subsequently accessed. We
obtained most of the register data via the Swiss Federal
Office of Public Health. Variables included a personal
identification number, date of birth, age at first regular
heroin use, date of admission to and cessation of each
treatment, and date of the first lifetime treatment
episode. Although the same database was used, most,
but not all, cantons supplied time-ranges of permissions
to treat a specific patient, lasting several months to a
year. Moreover, cantons collected age at first regular
heroin use to varying degrees.
Data from this database and other datasets were
analyzed, if cantonal health authorities agreed to
participate in the study. The following 11 cantons were
enrolled: Bern, Fribourg, Genève, Graubünden, Neuchâ-
tel, Schaffhausen, Solothurn, St. Gallen, Ticino, Vaud,
Zug, and Zurich. Additionally, we obtained the exact year
of birth of all patients in treatment on a specific day for
2c a n t o n s( A a r g a u ,2 8
th of January 2008, n = 812;
Solothurn, 17
th of January 2008, n = 621). We did not
approach most of the remaining 13 cantons because they
had limited sample sizes, generally having less than 100
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included in this part of the study represented about 70%
of the Swiss population in methadone treatment. These
11 cantons were spread throughout different linguistic
areas and included both urban and rural parts of
Switzerland.
Data preparation
We examined the data for consistency. If heroin onset
was recorded to be before the age of 12, if onset was not
recorded to be in the year of first substitution treatment
or before, or if discrepancies between a patient's year of
onset recorded in different treatment episodes were
greater than 3 years, the year of onset from this treatment
episode was considered as an error in the data and thus
deleted. If there were discrepancies in the year of onset
for an individual patient of 3 years or less, a mean value
was calculated and rounded accordingly. For the
remaining patients, we assumed that the missing data
did not strongly deviate from the data obtained for the
14,396 (53%) patients with a known year of first regular
heroin use. For the RDA method we used all available
data from the 11 cantons included in this study. For the
GIF method we only used data from those calendar years
that had similar numbers of admissions and cessations.
This ensured that in the analyses, we only included data
from years in which a register had been fully operational.
Calculating incidence estimates using the RDA method
The RDA method aims to estimate and to correct for
those heroin users from each onset cohort, who have not
yet shown up in opioid substitution treatment. It
assumes a stable probability distribution that describes
the time between onset of heroin use and first treatment.
If we assume that almost every regular heroin user enters
his first substitution treatment (if ever) within 10 years, a
treatment register of ten years would be sufficient to
estimate a full probability distribution of that 'delay' or
'lag'. To estimate the lag time period between first regular
heroin use and first substitution treatment we applied
the method proposed by Hickman and colleagues [2]. To
avoid bias due to restricted availability of treatment slots
or missing data before 1997, we only included indivi-
duals (n = 2,709), who had begun using heroin regularly
between 1997 and 2006. We estimated the conditional
lag distribution of this 10-year period with a general
linear model using five parameters (a linear and a
quadratic term of the lag time and dummy variables for
the three shortest lag time periods), as in a former
publication [5].
The RDA method underestimates incidence because it
does not account for those heroin users, who do not
show up in treatment. Thus, we applied a cessation
correction of 4% per year, based on the assumption that
each heroin user observed in treatment is representative
of all those who had died or stopped heroin use before
having had the possibility to enter treatment. For
example, if a total of 44 individuals, who entered
treatment in 1997, reported initiating regular heroin
use in 1977, this suggests that 100 individuals had
started regularly using heroin in 1977 (= 0.96
20 years).
Estimating the annual probability of being in substitution
treatment (GIF)
We divided the annual number of individuals in
substitution treatment by the RDA incidence estimate
for each calendar year between 2001 and 2006 (n =
12,846 to n = 13,336). Since the data revealed a
preference for reporting even years of regular heroin
onset, we computed a three-period moving average using
t h ef o r m e r ,t h ec u r r e n t ,a n dt h ef o l l o w i n gv a l u e s .T h e
resulting treatment probabilities were plotted by time
since onset of regular heroin use.
Applying the GIF to year of first regular heroin use
To estimate incidence for each calendar year separately,
we applied an approximation formula for the General
Inclusion Function. This formula describes the prob-
ability of being in treatment at least 1 day during a year
(Pannum), depending on time since onset (in years):
Pannum
time- time- time  years =∗ − ∗ ≥
− 07 1 02 09 6 2
10 2 .(( . ) ). |
(. )
The components of this approximation formula can be
interpreted as follows: 0.7 is a linear scale factor and sets
the peak to 0.457; the term (1 – (time-0.2)
-1) describes
the steep rise in probability during the first years; after
some decades the decline approximates 4% per year
(0.96
(time-0.2)).
Estimating the number of affected individuals in each
birth cohort
The mean age at first regular heroin use was approxi-
mately 21 years in all cantons over all treatment years.
Thus, we estimated the number of affected individuals in
each birth cohort in cantons providing detailed data by
supposing a constant age of onset of 21 years and
applying the approximation formula for the General
Inclusion Function.
Approximating incidence, using estimates of the number
of affected individuals in each birth cohort
Shifting the time scale by 21 years – the mean age of
onset of regular heroin use – allowed comparisons to be
made between incidence estimates based on age of onset
data and those based on birth cohort data. Theoretically,
the narrower the age of onset distribution, the more
similar the two forms of incidence estimates.
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birth cohort, using data in age groups, published in annual
treatment statistics
Between 1999 and 2006, 24 out of 26 cantons published
the number of patients in treatment by 5-year age group
categories over at least several years [7]. To estimate how
many individuals of a specific age were in treatment per
year, we divided the published number of patients
within each age group by 5. We assumed that the
r e s u l t i n gn u m b e rw a st h eb e s te s t i m a t ef o rt h es i z eo ft h e
specific group, whose age corresponds to the mean age of
the category. We obtained a value for the number of
patients aged 22, 27, 32 and 37 for each treatment year
between 1999 and 2006. This procedure led to the
number of individuals in treatment for each birth cohort
between 1962 and 1984. When we obtained more than
one number for a specific birth cohort, we used the value
from the most recent treatment year. Although only 7
out of 24 cantons had published data on age groups for
each year between 1999 and 2006, 15 out of 24 cantons
had data available from 2002 to 2005. For the canton of
Basel-Stadt we had to rely on a publication that only
provided 10-year age group categories [9]. Therefore, for
this canton we modified our procedure accordingly.
In cantons for which we could recalculate the numbers of
patients in treatment using treatment case register data, we
found some differences in the size of age groups. Since we
were interested in how well the procedure using 5-year age
group categories fitted estimates using numbers of patient
of each birth cohort from treatment case registers, we used
our own calculated annual numbers of 5-year age group
categories.
Results
For 11 cantons we had complete methadone treatment
register data from 1998 to 2006 (Table 1). The mean
annual number of patients treated during the respective
years varied from 3,701 in the canton of Zurich to 79 in
the canton of Zug. The mean age was approximately
35 years and the mean age of onset of regular heroin use
was approximately 21 years. The proportion of cases
with known age of onset ranged from 6% to 90%
between cantons. In most cantons and during all
treatment years the mean age of patients with unknown
age of onset was about 3 years higher than the age of
patients with known age of onset.
Data from the case registers of all 11 participating cantons
showed that in total 27,047 patients had entered substitu-
tion treatment until the end of 2006. The RDA method
revealed that heroin users entered their first substitution
treatmentsoonafteronset,i.e.22.6%enteredtwoyearsafter
onset (Figure 1), if they did so within the period of 10 years
that was covered by the data. Thus, summing the lag-time
distribution up to year two, we see that one half of heroin
users (49.5%) entered substitution treatment for the first
time within two years of onset.
Adjustment of the observed incidence number by the
lag-time distribution and cessation correction only
affected the overall shape of the heroin incidence curve
to a small extent (Figure 2). The adjusted incidence curve
indicates that heroin use first began in 1966 with 15
individuals. Following this there was a steep rise in
heroin incidence, which peaked in 1990 with 2,572 new
users, and then a steep decline to 686 users in 2002.
Incidence levels have remained stable since then.
Applying the GIF approach, a steep increase in the
proportion of regular heroin users in treatment is
observed during the first years after onset (Figure 3).
Between 2001 and 2006, 5 years after onset of regular
heroin use between 42.8% and 50.2% of users were in
substitution treatment for at least 1 day. The proportion
of heroin users in treatment declined slowly to about
21% three decades after onset.
Table 1: Methadone treatment case-register data
Treatment years
included
Number of
patients (mean)
Age (mean) Age at first regular
heroin use (mean)
Proportion with
known onset (mean)
Zurich 1998–2006 3,701 35.4 21.5 76%
Bern 1999–2005 2,650 34.8 20.9 50%
Genève 1999–2006 1,581 37.3 20.1 16%
Vaud 2001–2006 1,684 36.0 20.8 36%
Ticino 1998–2006 987 35.5 20.8 90%
St. Gallen 2001–2007 910 35.2 22.9 31%
Neuchâtel 2000–2006 689 36.1 21.1 32%
Fribourg 1999–2005 496 33.4 20.2 51%
Graubünden 1998–2006 267 34.3 19.7 6%
Schaffhausen 2000–2006 140 33.9 19.2 28%
Zug 2006 79 36.2 20.8 72%
Methadone treatment case-registers data from 11 cantons of Switzerland, 1998–2008.
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estimates when the GIF approximation formula is
applied to the joint dataset of the 11 cantons. It shows
that this formula yields similar results using the annual
number of patients from 2001 to 2006, respectively. The
right panel in figure 4 shows the results of the
application of the approximation formula on year of
birth when imputing a constant age of onset of 21 years
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Figure 1
Lag-time distribution (RDA). Joint lag-time distribution
between onset of regular heroin use and first visit to a
substitution treatment facility in the 11 cantons of
Switzerland that provided year of onset, 1997–2006.
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Incidence by the RDA method. Joint incidence of regular
heroin use in the 11 cantons of Switzerland that provided
year of onset estimated by the RDA method, 1966–2006.
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Figure 3
Annual treatment probability by time since onset
(GIF). Joint annual probability of being in treatment for at
least one day among all regular heroin users of the 11
cantons of Switzerland that provided year of onset, 2001–
2006.
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Figure 4
Incidence and affected birth cohorts by the GIF
method. Joint incidence of regular heroin use and affected
birth cohorts in the 11 cantons of Switzerland that provided
year of onset; annual estimates by the GIF method using
number of patients, 2001–2006.
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formula yields similar results using the annual number
of patients from 2001 to 2006, respectively. Results
indicate that with approximately 2,000 individuals in
each cohort, the birth cohorts between 1965 and 1969
were most affected by regular heroin use.
The annual incidence estimates from all 11 cantons were
very similar, especially within those cantons with a high
number of methadone treatments and a high proportion
of known years of onset. Figure 5 shows the time trends
of standardized incidence estimates in all cantons of
Switzerland. The bold line indicates the best incidence
estimates using year of onset. Incidence trends were
similar between almost all cantons with a clear peak in
the very early 90s, except for the canton of St. Gallen
(SG). The 2 thinner lines depict the incidence trends,
calculated by year of birth, shifted by 21 years. Even
though the overall trend of all 3 lines is similar within
cantons, the trends calculated by year of birth generally
show a less pronounced peak.
Figure 6 displays approximated incidence trends over
time in each canton of Switzerland. Darker colors
represent higher incidence rates. Using estimates of the
number of affected individuals born between 1962 and
1969 and initiating regular heroin use around 1986, we
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Figure 5
Standardized incidence estimates by the GIF
method. Standardized estimates of incidence of regular
heroin use per 1,000 population and its approximation by
using year of birth or 5-year age group categories from
annual tables of all 26 cantons of Switzerland, 1970–2005.
Gaps in lines derive from missing annual tables in the
National Statistic of Methadone Treatment between 1999
and 2006 [7].
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Figure 6
Evolution of the 'heroin epidemic'. Evolution of the
'heroin epidemic' in 3 phases using approximated incidence
trends of regular heroin use per 1,000 population during 2
decades in all 26 cantons of Switzerland. The darker the area
the higher the affected birth cohorts in the respective
canton, using 5-year age group categories from annual
statistic tables between 1999 and 2006.
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with higher incidence rates. These regions were spread
over all linguistic areas of Switzerland. Over the years,
differences in incidence rates between cantons disap-
peared and heroin incidence now seems to have
stabilized at a comparatively low and equal level
throughout Switzerland.
Discussion
This study has shown that the GIF method allows us to
estimate the incidence of regular heroin use even in
small areas or with incomplete data. By joining long-
term treatment register data from 11 cantons, we found
that in Switzerland one half of regular heroin users had
entered substitution treatment for the first time within
two years of onset. Since the 11 cantons included in the
study provide approximately 70% of all opioid substitu-
tion treatments in Switzerland, we estimate that in the
whole of Switzerland, the incidence of regular heroin use
peaked with about 3,675 new users in 1990, and that
about 1,000 individuals began regularly using heroin per
year from 2001 onwards.
In all cantons, the mean age of onset of regular heroin
use was about 21. Therefore, supposing a constant age of
onset of 21 years and applying the GIF method we
estimate that for the whole of Switzerland the birth
cohorts between 1965 and 1968 were most affected with
approximately 2,800 (≈2,000/0.7) individuals initiating
regular heroin use.
Using year of birth and assuming onset of regular heroin
use at the age of 21 years led to reasonably good
approximations of incidence estimates obtained by real
age of onset. If we suppose that any short peak of heroin
incidence will affect young people at around the age of
20, it follows that birth cohort incidence curves will be
less steep and smoother than year of onset incidence
curves. The results from different Swiss cantons showed
some support for this assumption, with birth cohort
trend estimates peaking a few years earlier at lower
levels.
Given the relatively high proportion of missing data on
age of onset, the variation in the proportion of missing
data between cantons and the fact that the mean age of
those patients with missing data on age of onset was
about 3 years higher than that of patients with available
data, we must be careful when comparing incidence
trends between cantons. If data concerning age of onset
is of poor quality, using year of birth and calculating
incidence by birth cohort, may lead to better estimates.
Among our incidence estimates, the canton of St. Gallen
is a good example, where a rather pronounced difference
between birth cohort estimates and year of onset
estimates point to possible weaknesses in the quality of
data on age of onset. However, even if birth cohort
estimates are more robust, they do not necessarily
correspond fully to onset incidence trends.
In almost all cantons with elevated incidence levels, the
birth cohorts of the late 60s and the early 70s were most
a f f e c t e db yh e r o i nu s e .D u et ot h es m a l ls i z eo fs o m e
cantons and some data of debatable quality, we think
that grouping estimates into 7-year periods is more
appropriate than speculating about the 'irregularities' of
estimated trends. Despite this low time resolution, our
representation of the spread of the 'heroin epidemic' in
its spatial and temporal dimensions is still meaningful. It
clearly reveals that there were several regions with higher
incidence rates during the 80s. These 'centers' are
distributed throughout all linguistic regions of Switzer-
land. This might be surprising since open drug scenes
have only been known to exist in the German part of
Switzerland. Thus, we have no indication of whether the
' h e r o i nw a v e 'b e g u ni nt h ee a s t e r no ri nt h en o r t h e r np a r t
of Switzerland, nor whether it spread from a centre – for
example, from Zurich, with its more prominent open
drug scenes. Over the last 2 decades, the former spatial
differences seem to have disappeared and the incidence
of regular heroin use has stabilized at a comparatively
low level throughout Switzerland.
Apart from the afore-mentioned limitations, our
approach should not be understood as providing the
'best possible estimate' of the incidence of regular heroin
use for each canton of Switzerland. In this paper, we
neglected the number of opioid users in heroin-assisted
treatment programs. This form of treatment exists in
about half of all cantons in Switzerland, most often in
the German part [10]. But as the proportion of opioid
users in heroin-assisted treatment amounts only to about
10% of those in methadone treatment, this would not
lead to substantially different results. A probably greater
influence on estimates in specific cantons is the implicit
assumption that there was no long-term drift of heroin
users towards more urban regions. Short-term drifts are
less probable because of the activities of cities with open
drug scenes that aimed to 'repatriate' users of illegal
drugs to their former living community (see for example
a project established in 1993 in the city of Zurich [11]).
However, a long-term shift may have led to an under-
estimation of incidence trends in smaller cantons, where
trends are difficult to estimate due to small numbers.
Taken together, we recommend that incidence estimates
for each calendar year should not be made for areas with
less than 300 patients in substitution treatment. For
greater time-frames even about 100 patients in substitu-
tion treatment will be sufficient.
Substance Abuse Treatment, Prevention, and Policy 2009, 4:14 http://www.substanceabusepolicy.com/content/4/1/14
Page 7 of 8
(page number not for citation purposes)Conclusion
Using a simple method to estimate the incidence of
heroin use, we were able to show that it is also possible
to estimate incidence trends in relatively small areas and
with incomplete data.
As to the spread of the heroin wave in Switzerland, in all
cantons incidence peaked at the beginning of the 90s.
Those cantons with higher incidence rates during the 80s
were not necessarily those cantons where open drug
scenes were present. Over the last 2 decades the former
spatial differences in Switzerland seem to have disap-
peared, and the incidence of regular heroin use has
stabilized at a comparatively low level throughout
Switzerland.
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